Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 55 results for "astrazeneca"

AstraZeneca Pharma Q3 net up 84% to Rs 16 cr
Money Control

AstraZeneca Pharma jumps nearly 7% after solid Q3

Shares of AstraZeneca Pharma today advanced by nearly 7 per cent after the firm reported a whopping 84 per cent increase in its standalone net profit for the third quarter to December. DNA, 2 weeks ago
AstraZeneca Pharma Q3 net up 84% to Rs 16 cr Money Control, 2 weeks ago

687 images for astrazeneca

American Banking News, 2 weeks ago
SleekMoney, 2 weeks ago
SleekMoney, 2 weeks ago, 2 weeks ago
WKRB News, 2 weeks ago, 2 weeks ago, 2 weeks ago
American Banking News, 2 weeks ago
Reuters UK, 2 weeks ago
Yahoo! UK and Ireland, 2 weeks ago

AstraZeneca Pharma India: Outcome of board meeting

AstraZeneca Pharma India Ltd has informed BSE about Outcome of Board Meeting held on February 02, 2017.
 Money Control2 weeks ago Board of AstraZeneca Pharma India approves change in directorate  Business Standard2 months ago

Cadila Healthcare to buy 8 brands from AstraZeneca India: Srcs

AstraZeneca's products are used for treatment of cough, pain and in neurology. The brands included in the deal are Bricarex, Bricarex-A, Bricanyl, Xylocard, Ceriviprime, Prostodin, Partocin and Primiprost.
 Money Control1 month ago AstraZeneca Pharma India  Business Line2 months ago AstraZeneca Pharma India intimates of extension of distribution arrangements for Meronem  Business Standard2 months ago AstraZeneca gets 6-mth extension to sell Meronem in India  Money Control2 months ago

Results to watch out for! Glenmark, Marico, Godrej Properties in focus

The results which are expected today are Glenmark, Godrej Properties, Marico, HCC, Dr Lal PathLabs, Aegis Logistics, Astrazeneca Pharma, TeamLease, Godfrey Phillips, Vijaya Bank.
 India Infoline2 weeks ago Glenmark Pharma, Marico, HCC results  Business Line2 weeks ago

Narayan Seshadri elected AstraZeneca Pharma India Chairman

Drug firm AstraZeneca Pharma India has said its board has elected independent director, Narayan K Seshadri, as chairman of the company. The board of directors at its meeting on December 2, 2016 has unanimously elected independent director ...
 Business Standard2 months ago

AstraZeneca flags falling profit while awaits key drug data

AstraZeneca warned on Thursday that profit and revenue would both fall this year as cheap generic versions of its cholesterol drug Crestor continue to hit sales. The British pharmaceuticals group hopes that 2017 will be the earnings trough, but its recovery ...
 Reuters2 weeks ago

GSK grabs Astra executive to replace exiting pharma head

GlaxoSmithKline said on Thursday that Abbas Hussain, its global head of pharmaceuticals, is leaving the company and will be replaced by Luke Miels from AstraZeneca. Hussain had been seen as a potential contender to take over from Chief Executive Andrew Witty, ...
 Reuters1 month ago GSK grabs AstraZeneca executive to replace pharma head  DNA1 month ago AstraZeneca oncology head jumps ship to become Innate CEO  Reuters2 months ago French cancer specialist Innate Pharma can remain independent, for now: CEO  Reuters2 months ago

AstraZeneca zooms by 2.84% on reports of granting rights to Pfizer

AstraZeneca Pharma has informed that the company has granted authority to Pfizer Limited for certain rights in relation to identified injectable antibiotic products through a delegation of authority (DoA).
 India Infoline1 month ago Pfizer receives rights from AstraZeneca  India Infoline1 month ago

Astra, Lilly stick with Alzheimer's approach despite setback

AstraZeneca will expand its collaboration with Eli Lilly to develop an experimental Alzheimer's drug, sticking with an approach that has been a mainstay of research despite recent setbacks. Astra said it would team up with Lilly to develop a drug known as ...
 Reuters2 months ago

AstraZeneca's Lynparza meets main goal in breast cancer study

AstraZeneca Plc said Lynparza, already approved to treat ovarian cancer, met the main goal of helping breast cancer patients live longer without their condition worsening in a late-stage study.
 DNA3 days ago AstraZeneca pill slashes lung cancer progression in study  Reuters2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less